These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7826212

  • 21. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins.
    Xu X, Ruo SL, McCormick JB, Fisher-Hoch SP.
    Am J Trop Med Hyg; 1992 Oct; 47(4):397-404. PubMed ID: 1359802
    [Abstract] [Full Text] [Related]

  • 22. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
    Selin LK, Vergilis K, Welsh RM, Nahill SR.
    J Exp Med; 1996 Jun 01; 183(6):2489-99. PubMed ID: 8676069
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Persistent infection of mice with Pichinde virus associated with failure to thrive.
    Wright KE, Ahmed R, Buchmeier MJ.
    Microb Pathog; 1995 Aug 01; 19(2):73-82. PubMed ID: 8577237
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P, Cardoso AI, Daviet L, Buckland R, Wild TF.
    Virology; 1996 May 01; 219(1):133-9. PubMed ID: 8623522
    [Abstract] [Full Text] [Related]

  • 26. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA, Brand TN, Lobigs M, Sangster MY, Howard MJ, Mackenzie JS.
    J Gen Virol; 1996 Jun 01; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [Abstract] [Full Text] [Related]

  • 27. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H, Lorenzo G, Rodriguez F, Brun A.
    Vaccine; 2011 Jun 15; 29(27):4469-75. PubMed ID: 21549790
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S, Mason PW, Konishi E, Fonseca BA, Shope RE, Rice CM, Paoletti E.
    Virology; 1992 Mar 15; 187(1):290-7. PubMed ID: 1736531
    [Abstract] [Full Text] [Related]

  • 30. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Apr 15; 89(7):3523-33. PubMed ID: 25589652
    [Abstract] [Full Text] [Related]

  • 31. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK, Nahill SR, Welsh RM.
    J Exp Med; 1994 Jun 01; 179(6):1933-43. PubMed ID: 8195718
    [Abstract] [Full Text] [Related]

  • 32. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.
    Stitz L, Schmitz C, Binder D, Zinkernagel R, Paoletti E, Becht H.
    J Gen Virol; 1990 May 01; 71 ( Pt 5)():1169-79. PubMed ID: 1693165
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF.
    Virology; 1997 Dec 22; 239(2):389-401. PubMed ID: 9434729
    [Abstract] [Full Text] [Related]

  • 35. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM, Ramirez JC, Rodríguez D, Rodríguez JR, Sano G, Zavala F, Esteban M.
    J Immunol; 1999 Jun 01; 162(11):6724-33. PubMed ID: 10352291
    [Abstract] [Full Text] [Related]

  • 36. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.
    Verardi PH, Aziz FH, Ahmad S, Jones LA, Beyene B, Ngotho RN, Wamwayi HM, Yesus MG, Egziabher BG, Yilma TD.
    J Virol; 2002 Jan 01; 76(2):484-91. PubMed ID: 11752138
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.
    Wyatt LS, Whitehead SS, Venanzi KA, Murphy BR, Moss B.
    Vaccine; 1999 Oct 14; 18(5-6):392-7. PubMed ID: 10519927
    [Abstract] [Full Text] [Related]

  • 39. Interferon alfacon-1 protects hamsters from lethal pichinde virus infection.
    Gowen BB, Barnard DL, Smee DF, Wong MH, Pace AM, Jung KH, Winslow SG, Bailey KW, Blatt LM, Sidwell RW.
    Antimicrob Agents Chemother; 2005 Jun 14; 49(6):2378-86. PubMed ID: 15917537
    [Abstract] [Full Text] [Related]

  • 40. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
    Pekosz A, Griot C, Stillmock K, Nathanson N, Gonzalez-Scarano F.
    J Virol; 1995 Jun 14; 69(6):3475-81. PubMed ID: 7745694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.